Clinical Trial Update: Influenza Vaccine Post Allogeneic Transplant [NA]

View source ↗

Summary

Clinical trial update for an influenza vaccine in patients after allogeneic hematopoietic stem cell transplant; the study was terminated and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Hematopoietic Stem Cell Transplant

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hematopoietic Stem Cell Transplant, Hematologic Malignancy | NA | Status: TERMINATED | Results posted: 2016-08-16